Gambit Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30M Sell
24,997
-1,003
-4% -$1.02M 17.45% 1
2026
Q1
$23.9M Buy
26,000
+1,424
+6% +$1.44M 16.47% 1
2025
Q4
$26.5M Buy
+24,576
New +$23.5M 18.99% 1

Other funds holding LLY

Gambit Capital Management's LLY Position: Q2 2026 in Review

Gambit Capital Management reduced its Eli Lilly (LLY) stake by 3.9% in Q2 2026, selling an estimated $1.02M and leaving 24,997 shares worth $30M. The position accounts for 17.45% of the portfolio, ranked #1.

Gambit Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gambit Capital Management held 24,997 shares of Eli Lilly worth $30M as of Q2 2026.
  • Gambit Capital Management sold 1,003 Eli Lilly shares in Q2 2026, an estimated $1.02M.
  • Eli Lilly made up 17.45% of Gambit Capital Management's portfolio in Q2 2026, its #1 holding.
  • Gambit Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gambit Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.